These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15008345)

  • 1. Adult tinea capitis due to Trichophyton violaceum in China.
    Yu J; Chen W; Wan Z; Li RY
    Mycopathologia; 2004 Jan; 157(1):49-52. PubMed ID: 15008345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tinea capitis by trichophyton violaceum in immuno-suppressed elderly man.
    Blasco Melguizo J; Ruiz Villaverde R; Delgado Florencio V; Buendía Eisman A
    J Eur Acad Dermatol Venereol; 2004 Jan; 18(1):100-2. PubMed ID: 14678545
    [No Abstract]   [Full Text] [Related]  

  • 3. Tinea capitis in adults in southern Spain. A 17-year epidemiological study.
    Lova-Navarro M; Gómez-Moyano E; Martínez Pilar L; Fernandez-Ballesteros MD; Godoy-Díaz DJ; Vera-Casaño A; Crespo-Erchiga V
    Rev Iberoam Micol; 2016; 33(2):110-3. PubMed ID: 26774593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole.
    Gupta AK; Adam P; Dlova N; Lynde CW; Hofstader S; Morar N; Aboobaker J; Summerbell RC
    Pediatr Dermatol; 2001; 18(5):433-8. PubMed ID: 11737692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tinea capitis in adults.
    Aste N; Pau M; Biggio P
    Mycoses; 1996; 39(7-8):299-301. PubMed ID: 9009649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China.
    Deng S; Hu H; Abliz P; Wan Z; Wang A; Cheng W; Li R
    Mycopathologia; 2011 Nov; 172(5):365-72. PubMed ID: 21701791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid response of Trichophyton tonsurans-induced onychomycosis after treatment with terbinafine.
    Aly R; Hafeez ZH; Rodwell C; Frieden IJ; Abrams B
    Int J Dermatol; 2002 Jun; 41(6):357-9. PubMed ID: 12100692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, randomized, comparative trial of itraconazole versus terbinafine for 2 weeks in tinea capitis.
    Jahangir M; Hussain I; Ul Hasan M; Haroon TS
    Br J Dermatol; 1998 Oct; 139(4):672-4. PubMed ID: 9892912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antifungal susceptibility of Trichophyton violaceum isolated from tinea capitis patients.
    Deng S; de Hoog GS; Verweij PE; Zoll J; Ilkit M; Morsali F; Abliz P; Wang X; Zhan P; Yang L; Hasimu H; Liao W; Pan W; Seyedmousavi S
    J Antimicrob Chemother; 2015 Apr; 70(4):1072-5. PubMed ID: 25492394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric tinea capitis caused by Trichophyton violaceum and Trichophyton soudanense in Rochester, Minnesota, United States.
    Grigoryan KV; Tollefson MM; Olson MA; Newman CC
    Int J Dermatol; 2019 Aug; 58(8):912-915. PubMed ID: 30548845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized double-blind comparative study of terbinafine for 1, 2 and 4 weeks in tinea capitis.
    Haroon TS; Hussain I; Aman S; Jahangir M; Kazmi AH; Sami AR; Nagi AH; Alvi KH; Iqbal N; Khan KA; Aziz R
    Br J Dermatol; 1996 Jul; 135(1):86-8. PubMed ID: 8776365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of terbinafine treatment of tinea capitis in children varies according to the dermatophyte species.
    Baudraz-Rosselet F; Monod M; Jaccoud S; Frenk E
    Br J Dermatol; 1996 Dec; 135(6):1011-2. PubMed ID: 8977737
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic efficacy of terbinafine in the treatment of three children with tinea tonsurans.
    Desgarennes MD; Godoy MR; Palencia AB
    J Am Acad Dermatol; 1996 Jul; 35(1):114-6. PubMed ID: 8682948
    [No Abstract]   [Full Text] [Related]  

  • 14. Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study.
    Friedlander SF; Aly R; Krafchik B; Blumer J; Honig P; Stewart D; Lucky AW; Gupta AK; Babel DE; Abrams B; Gourmala N; Wraith L; Paul C;
    Pediatrics; 2002 Apr; 109(4):602-7. PubMed ID: 11927703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing tinea capitis prevalence in Stockholm reflects immigration.
    Hällgren J; Petrini B; Wahlgren CF
    Med Mycol; 2004 Dec; 42(6):505-9. PubMed ID: 15682638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of dermatophyte isolates obtained from a large worldwide terbinafine tinea capitis clinical trial.
    Ghannoum MA; Wraith LA; Cai B; Nyirady J; Isham N
    Br J Dermatol; 2008 Sep; 159(3):711-3. PubMed ID: 18510668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo.
    Mock M; Monod M; Baudraz-Rosselet F; Panizzon RG
    Dermatology; 1998; 197(4):361-7. PubMed ID: 9873175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Trichophyton equinum infection treated with terbinafine.
    Burden AD; Tillman DM; Richardson MD
    Clin Exp Dermatol; 1994 Jul; 19(4):359-60. PubMed ID: 7955486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rising menace of antifungal resistance in dermatophytes among the patients of tinea capitis.
    Zeeshan F; Sabir M; Uddin F
    J Pak Med Assoc; 2023 Jan; 73(1):43-48. PubMed ID: 36842005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Trichophyton violaceum tinea in Switzerland].
    Baudraz-Rosselet F; Chabloz-Jaton T; Monod M
    Rev Med Suisse Romande; 1999 Jun; 119(6):503-6. PubMed ID: 10422477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.